Efferth T - Search Results

1

Effect of artesunate on immune cells in ret-transgenic mouse melanoma model.

Ramacher M, Umansky V, Efferth T. Ramacher M, et al. Among authors: efferth t. Anticancer Drugs. 2009 Nov;20(10):910-7. doi: 10.1097/CAD.0b013e328330caba. Anticancer Drugs. 2009. PMID: 19745721

2

Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells.

Efferth T, Giaisi M, Merling A, Krammer PH, Li-Weber M. Efferth T, et al. PLoS One. 2007 Aug 1;2(8):e693. doi: 10.1371/journal.pone.0000693. PLoS One. 2007. PMID: 17668070 Free PMC article.

3

Effect of artemisinins and other endoperoxides on nitric oxide-related signaling pathway in RAW 264.7 mouse macrophage cells.

Konkimalla VB, Blunder M, Korn B, Soomro SA, Jansen H, Chang W, Posner GH, Bauer R, Efferth T. Konkimalla VB, et al. Among authors: efferth t. Nitric Oxide. 2008 Sep;19(2):184-91. doi: 10.1016/j.niox.2008.04.008. Epub 2008 Apr 22. Nitric Oxide. 2008. PMID: 18472018 Free PMC article.

4

Artesunate derived from traditional Chinese medicine induces DNA damage and repair.

Li PC, Lam E, Roos WP, Zdzienicka MZ, Kaina B, Efferth T. Li PC, et al. Among authors: efferth t. Cancer Res. 2008 Jun 1;68(11):4347-51. doi: 10.1158/0008-5472.CAN-07-2970. Cancer Res. 2008. PMID: 18519695

5

The antiviral activities of artemisinin and artesunate.

Efferth T, Romero MR, Wolf DG, Stamminger T, Marin JJ, Marschall M. Efferth T, et al. Clin Infect Dis. 2008 Sep 15;47(6):804-11. doi: 10.1086/591195. Clin Infect Dis. 2008. PMID: 18699744 Review.

6

The role of downstream signaling pathways of the epidermal growth factor receptor for Artesunate's activity in cancer cells.

Konkimalla VB, McCubrey JA, Efferth T. Konkimalla VB, et al. Among authors: efferth t. Curr Cancer Drug Targets. 2009 Feb;9(1):72-80. doi: 10.2174/156800909787314020. Curr Cancer Drug Targets. 2009. PMID: 19200051

7

Gene expression profiling identifies novel key players involved in the cytotoxic effect of Artesunate on pancreatic cancer cells.

Youns M, Efferth T, Reichling J, Fellenberg K, Bauer A, Hoheisel JD. Youns M, et al. Among authors: efferth t. Biochem Pharmacol. 2009 Aug 1;78(3):273-83. doi: 10.1016/j.bcp.2009.04.014. Epub 2009 Apr 22. Biochem Pharmacol. 2009. PMID: 19393226 Free article.

8

Combination treatment of malignant B cells using the anti-CD20 antibody rituximab and the anti-malarial artesunate.

Sieber S, Gdynia G, Roth W, Bonavida B, Efferth T. Sieber S, et al. Among authors: efferth t. Int J Oncol. 2009 Jul;35(1):149-58. doi: 10.3892/ijo_00000323. Int J Oncol. 2009. PMID: 19513562

9

Factors determining sensitivity or resistance of tumor cell lines towards artesunate.

Sertel S, Eichhorn T, Sieber S, Sauer A, Weiss J, Plinkert PK, Efferth T. Sertel S, et al. Among authors: efferth t. Chem Biol Interact. 2010 Apr 15;185(1):42-52. doi: 10.1016/j.cbi.2010.02.002. Epub 2010 Feb 6. Chem Biol Interact. 2010. PMID: 20144594

10

First evidence that the antimalarial drug artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases.

Rasheed SA, Efferth T, Asangani IA, Allgayer H. Rasheed SA, et al. Among authors: efferth t. Int J Cancer. 2010 Sep 1;127(6):1475-85. doi: 10.1002/ijc.25315. Int J Cancer. 2010. PMID: 20232396

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

866 results

Search Page

Filters